These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
850 related articles for article (PubMed ID: 9335513)
1. Docetaxel in combination chemotherapy for metastatic breast cancer. Khayat D; Antoine E Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-19-S13-26. PubMed ID: 9335513 [TBL] [Abstract][Full Text] [Related]
2. Docetaxel (Taxotere) in combination: a step forward. Burris HA; Fields S; Peacock N Semin Oncol; 1995 Dec; 22(6 Suppl 13):35-40. PubMed ID: 8604452 [TBL] [Abstract][Full Text] [Related]
3. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors. Valero V Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540 [TBL] [Abstract][Full Text] [Related]
4. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58. Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263 [TBL] [Abstract][Full Text] [Related]
6. Docetaxel (Taxotere) plus doxorubicin-based combinations: the evidence of activity in breast cancer. Nabholtz JM Semin Oncol; 1999 Jun; 26(3 Suppl 9):7-13. PubMed ID: 10426453 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel couplets with cyclophosphamide or cisplatin in metastatic breast cancer. Tolcher AW Semin Oncol; 1996 Feb; 23(1 Suppl 1):37-43. PubMed ID: 8629035 [TBL] [Abstract][Full Text] [Related]
9. A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer. Trent JC; Valero V; Booser DJ; Esparza-Guerra LT; Ibrahim N; Rahman Z; Vernillet L; Patel S; David CL; Murray JL; Cristofanilli M; Hortobagyi GN Clin Cancer Res; 2003 Jul; 9(7):2426-34. PubMed ID: 12855614 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel and anthracycline polychemotherapy in the treatment of breast cancer. Nabholtz JM; Smylie M; Mackey J; Au HJ; Tonkin K; Au R; Morrish D; Salter E Semin Oncol; 1999 Jun; 26(3 Suppl 8):47-52. PubMed ID: 10403474 [TBL] [Abstract][Full Text] [Related]
11. Future perspectives of docetaxel (Taxotere) in front-line therapy. Piccart MJ; Di Leo A Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-27-S10-33. PubMed ID: 9275004 [TBL] [Abstract][Full Text] [Related]
12. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer. Belani CP Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542 [TBL] [Abstract][Full Text] [Related]
13. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer. Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894 [TBL] [Abstract][Full Text] [Related]
14. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer. Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517 [TBL] [Abstract][Full Text] [Related]
15. Docetaxel (Taxotere) in combination with anthracyclines in the treatment of breast cancer. Nabholtz JM; North S; Smylie M; Mackey J; Au HJ; Au R; Morrish D; Salter E; Tonkin K Semin Oncol; 2000 Apr; 27(2 Suppl 3):11-8. PubMed ID: 10810933 [TBL] [Abstract][Full Text] [Related]
16. Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies. Sparano JA Semin Oncol; 1998 Dec; 25(6 Suppl 13):10-5. PubMed ID: 9865686 [TBL] [Abstract][Full Text] [Related]
17. Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma. Rivera E; Valero V; Cristofanilli M; Frye DK; Booser DJ; Rosales MM; Hortobagyi GN Cancer; 2002 May; 94(9):2321-6. PubMed ID: 12015755 [TBL] [Abstract][Full Text] [Related]
18. Single-agent docetaxel (Taxotere) in randomized phase III trials. Burris HA Semin Oncol; 1999 Jun; 26(3 Suppl 9):1-6. PubMed ID: 10426452 [TBL] [Abstract][Full Text] [Related]
19. Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer. Campone M; Fumoleau P; Delecroix V; Deporte-Fety R; Perrocheau G; Vernillet L; Borg-Olivier O; Louboutin JP; Bissery MC; Riva A; Azli N Ann Oncol; 2001 Jul; 12(7):909-18. PubMed ID: 11521794 [TBL] [Abstract][Full Text] [Related]
20. Taxane-based three-drug combination in metastatic and adjuvant treatment of breast cancer. Nabholtz JM; Mackey J; Smylie M; Tonkin K Semin Oncol; 1998 Oct; 25(5 Suppl 12):27-31. PubMed ID: 9865709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]